Can Weed Cause Restless Legs? What Research Shows

Cannabis does not appear to cause restless legs syndrome (RLS) based on current evidence, and a handful of small studies actually suggest it may relieve symptoms in some people. The picture is not that simple, though. When regular users stop, periodic limb movements during sleep tend to increase, and long-term cannabis use affects the same dopamine pathways implicated in RLS. The research base is surprisingly thin for such a common question, and the studies that do exist are small, uncontrolled, and far from definitive.

What Small Studies Show About Symptom Relief

The most striking reports come from case series and exploratory trials rather than large controlled studies. One case series looked at patients with severe to very severe RLS who were already on standard medications like dopamine agonists, pregabalin, or opiates. Almost all of them reported complete or near-complete improvement in their RLS symptoms after smoking marijuana. Three patients later tried sublingual CBD instead, but they said smoking provided more relief.¹

A more recent exploratory trial tracked 18 people with RLS over three months of medical cannabis use. The researchers found that restless legs severity improved within the first month and stayed better through three months. People also spent less time lying awake after initially falling asleep. About a third of participants saw at least a 50% improvement in their RLS severity scores. But the study had no comparison group, so it is impossible to separate the effect of the medicine from placebo response or natural fluctuation in symptoms.² A separate small survey found that half of the RLS patients who tried medical marijuana reported symptom relief, though the sample was just four people.²

A scoping review that pulled together seven studies meeting its inclusion criteria concluded that cannabis or cannabidiol may improve or prevent RLS symptoms.¹ That “may” is doing heavy lifting. The review authors, along with a separate narrative review of cannabis for sleep disorders, emphasized that the evidence is currently insufficient to support routine use of cannabis for RLS or any sleep disorder.¹ These findings are interesting leads, not established medical guidance.

When Stopping Cannabis May Trigger Leg Symptoms

Here is where the relationship gets more uncomfortable for regular users. Even if cannabis itself does not cause RLS, quitting after prolonged heavy use may bring on a related problem. A sleep-lab study of marijuana users found that during abstinence, periodic limb movements (PLMs) during sleep increased. Total sleep time and sleep efficiency dropped, while time spent awake after falling asleep went up. Heavier users, both in terms of how many joints per week and how many years of use, had more pronounced increases in limb movements.³

A separate study in adolescents confirmed the same pattern: PLMs increased following abstinence from heavy marijuana use, even though most other sleep abnormalities cleared up within a few weeks.⁴ This is worth pausing on because it suggests that regular cannabis use may suppress limb movements while active, but those movements rebound, sometimes worse than before, when the drug is removed. The heavier and longer the use, the stronger the rebound appears to be.

This rebound effect could easily feel like new-onset RLS to someone who quits cannabis after years of use. You might never have had restless legs before, stop smoking, and suddenly find your legs twitching at night. It does not mean cannabis “caused” RLS in the sense of creating a new disease. But it may have masked symptoms or reset the baseline so that withdrawal unmasks movement issues that were there all along, or creates temporary ones as the nervous system readjusts.

Periodic Limb Movements and Restless Legs Are Not the Same Thing

One important distinction often lost in these discussions: periodic limb movements during sleep and restless legs syndrome are related but separate conditions. PLMs are involuntary, repetitive leg jerks that happen during sleep, usually every 20 to 40 seconds. You may not even know they are happening unless a bed partner notices or a sleep study picks them up. RLS, by contrast, is a conscious, uncomfortable urge to move your legs, typically when you are awake and trying to rest. Most people with RLS have PLMs, but many people with PLMs never experience the waking discomfort of RLS.

The cannabis withdrawal studies measured PLMs, not RLS per se. So while the evidence clearly shows that stopping cannabis increases nighttime leg movements, it does not prove that quitting cannabis causes the full-blown waking restlessness and discomfort that defines RLS. That said, people who are already prone to RLS might find that withdrawal pushes them over the threshold into noticeable symptoms, and anyone who experiences more nighttime leg movements is going to sleep worse regardless of whether they meet the formal diagnostic criteria.

The Dopamine Connection

RLS is fundamentally a dopamine problem. The uncomfortable sensations and urge to move are tied to how dopamine functions in certain brain regions, which is why dopamine-boosting medications are a first-line treatment. Cannabis intersects with dopamine in a way that may explain both the short-term relief and the long-term risk.

When you use THC acutely, it causes increased dopamine release and heightened dopamine neuron activity. That dopamine surge could plausibly explain why people with RLS feel rapid relief after smoking. But long-term use tells a different story: chronic THC exposure is associated with a blunting of the dopamine system.⁵ A dopamine system that has been dampened by years of cannabis use might not function as well on its own once the drug is removed, potentially worsening the very dopamine-related symptoms that RLS involves.

This creates a concerning theoretical loop. Cannabis provides short-term dopamine-mediated relief for restless legs. But sustained use gradually dulls the dopamine system. When the person stops, dopamine function is now lower than where it started, and RLS symptoms come back, possibly worse than before. That pattern would mirror what happens with the dopamine agonist medications sometimes prescribed for RLS, where long-term use can lead to augmentation, a well-known phenomenon in which the treatment eventually worsens the condition it was meant to help.

Endocannabinoids and Movement Control

Beyond dopamine, there is a broader story about how your body’s own cannabis-like chemicals interact with the brain circuits responsible for voluntary movement. The basal ganglia, a set of deep brain structures that help control movement, have a high density of CB1 cannabinoid receptors. Animal research has shown that endocannabinoid signaling in the globus pallidus, a specific region of the basal ganglia, is linked to motor control and may be relevant to movement disorders.⁶ The researchers suggested that targeting the endocannabinoid system could prove useful for basal ganglia-related movement disorders.

RLS is not typically classified as a basal ganglia disorder in the same way Parkinson’s is, but the two share some neurological infrastructure, particularly the dopamine-dependent circuits that regulate sensory processing and motor output. The fact that the endocannabinoid system is so densely wired into these circuits helps explain why cannabis has any effect on RLS at all. It also raises the possibility that flooding these receptors with external THC, day after day, could reshape how the movement-control system works in ways we do not fully understand yet.

Why the Research Is So Far Behind

Given how many people use cannabis and how common RLS is, it is surprising that the entire evidence base comes down to a handful of case series and small uncontrolled trials. A scoping review searching for studies on cannabis and RLS started with over 5,000 records and found only seven that met its inclusion criteria.¹ None of those were large randomized controlled trials. The review authors explicitly called for robust clinical trials to determine whether cannabis has a genuine therapeutic role in RLS.

Several factors explain the gap. Cannabis research in general has been slowed by regulatory barriers in many countries, making controlled trials expensive and bureaucratically painful to run. RLS, while quite common, is not life-threatening and tends to attract less research funding than conditions like cancer or heart disease. And the patients who report the most dramatic relief tend to be those with treatment-resistant RLS, a relatively small subgroup that is harder to recruit for formal studies. A narrative review of cannabis for sleep disorders reached a blunt conclusion: there is currently insufficient evidence to support the routine use of medicinal cannabis as an effective and safe treatment for any sleep disorder, RLS included.¹

Treatment-Resistant RLS and the Appeal of Cannabis

For most people with RLS, standard treatments work reasonably well. Dopamine agonists, certain anticonvulsants, and in some cases low-dose opiates keep symptoms manageable. But a subset of patients does not respond to any of these, or develops augmentation, where the medication that once helped starts making the symptoms worse and spreading them to other parts of the body. Augmentation is a recognized and frustrating complication of long-term dopamine agonist therapy.

It is in this treatment-resistant group that the most enthusiastic reports of cannabis relief have emerged. Patients who had tried multiple medications without success have described remarkable and total remission of their symptoms after using cannabis.⁷ These are compelling stories, and researchers have noted that convincing treatment alternatives are lacking for refractory cases. The pain-blocking effects of cannabis, documented across many neurological conditions, provide a plausible mechanism for why it might help when other things have failed.

The challenge is that personal reports and case series are the weakest form of evidence. People with severe symptoms are the most motivated to try unconventional treatments and the most likely to notice improvement, real or perceived. Placebo effects in RLS are known to be large. Without controlled comparisons, it is impossible to say how much of the reported relief is pharmacological and how much is expectation. That does not mean the relief is not real for those individuals, but it does mean we cannot generalize from their experience to everyone with RLS.

Smoked Cannabis vs. CBD Products

Not all cannabis is the same, and the form of delivery seems to matter. In the case series of severe RLS patients, three who were switched from smoked marijuana to sublingual CBD reported that smoking provided greater relief.¹ This is a tiny sample, but it tracks with what you would expect pharmacologically. Smoking delivers THC to the brain in seconds, producing a rapid dopamine release. Sublingual CBD works through different mechanisms, primarily anti-inflammatory and anxiolytic pathways, with a much slower onset and no direct dopamine surge.

For someone whose RLS symptoms are driven primarily by the dopamine deficit, CBD alone may not hit the right target. For someone whose symptoms are worsened by anxiety or pain, CBD could theoretically help through those alternative routes. The exploratory trial that tracked patients over three months used a medical cannabis product rather than isolated CBD, and it showed benefit, but again without a control group. The honest answer is that we do not yet know which cannabinoids, at which doses, through which delivery routes, are most likely to help. Anyone choosing to try cannabis for RLS is essentially running their own uncontrolled experiment.

Practical Considerations if You Have RLS

If you have RLS and are curious about cannabis, a few things are worth keeping in mind. First, standard treatments with a much stronger evidence base exist. Iron supplementation, when iron stores are low, can substantially improve RLS. Medications prescribed by a sleep specialist or neurologist are the foundation of treatment for moderate to severe cases. Cannabis should not be a first resort.

Second, if you are already a regular cannabis user and you develop restless legs or worsening leg movements during a break or quit attempt, the cannabis withdrawal effect on periodic limb movements is a likely contributor. This does not mean you need to keep using cannabis to manage it. In adolescents, most sleep abnormalities from cannabis withdrawal resolved within several weeks.⁴ Waiting it out, possibly with temporary support from a doctor, is a reasonable approach.

Third, the dopamine-blunting effect of long-term THC use is real and broad, affecting motivation, reward processing, and potentially movement regulation. If you use cannabis daily for years, you are reshaping the same neurological systems that RLS involves. Whether this translates into a clinically meaningful increase in RLS risk is unknown, but the mechanism is there, and the rebound data from withdrawal studies is suggestive.

What Researchers Want to Know Next

The most pressing gap is a properly randomized, placebo-controlled trial of cannabis in RLS patients. The exploratory trial that showed benefit over three months was open-label, meaning participants knew they were getting the active treatment, and there was no comparison arm.² Without blinding and a placebo group, the results, while encouraging, cannot separate drug effects from everything else that changes when someone enrolls in a study and expects improvement.

Researchers are also interested in whether specific cannabinoid profiles work better than others, whether tolerance develops over time the way it does with dopamine agonists, and whether the dopamine-blunting effect of chronic THC creates its own version of augmentation. Long-term follow-up data simply does not exist. The patients who report dramatic relief after years of failed treatments represent an important signal, but following them for several more years is the only way to know whether that relief holds up or erodes. Until those studies happen, the question of whether cannabis helps or harms restless legs will remain genuinely unanswered, even though early hints lean cautiously toward benefit for a subset of patients with severe, treatment-resistant disease.

1
PubMed Central. Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review
2
SLEEP. Prevalence of Cannabis Use in Patients with Restless Leg Syndrome for Symptomatic Relief
3
PubMed Central. Polysomnogram Changes in Marijuana Users Reporting Sleep Disturbances during Prior Abstinence
4
PubMed Central. Sleep architecture in adolescent marijuana and alcohol users during acute and extended abstinence
5
PubMed Central. The effects of Δ9-tetrahydrocannabinol on the dopamine system
6
PubMed. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease
7
Springer Link. Cannabis for Restless Legs Syndrome